Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neurosense Therapeutics Ltd (NRSN)

Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neurosense Therapeutics Ltd 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 ISR

www.neurosense-tx.com Employees: 18 P: 972-9799-6183

Description:

NeuroSense Therapeutics Ltd. is a clinical-stage biotechnology company. It focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, such as ALS, Alzheimer's and Parkinson's disease. NeuroSense Therapeutics Ltd. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 17,354
Enterprise Value, $K 14,714
Shares Outstanding, K 13,666
Annual Sales, $ 0 K
Annual Net Income, $ -11,280 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,400 K
EBIT, $ -2,990 K
EBITDA, $ -2,890 K
60-Month Beta 1.58
% of Insider Shareholders 27.40%
% of Institutional Shareholders 1.04%
Float, K 9,922
% Float 72.60%
Short Volume Ratio 0.38

Growth:

1-Year Return 148.48%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.35 on 06/24/24
Next Earnings Date 11/26/24
Earnings Per Share ttm -0.85
EPS Growth vs. Prev Qtr -118.75%
EPS Growth vs. Prev Year -6.06%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NRSN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.12
Interest Coverage -4.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar